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MIDLIFE DEMOGRAPHIC AND LIFESTYLE CHARACTERISTICS AND 
DEMENTIA IN THE FRAMINGHAM HEART STUDY OFFSPRING COHORT 
MATTHEW OGRODNIK 
ABSTRACT 
Background  
Dementia is the leading cause of dependence and disability in the elderly 
population worldwide. Effectively addressing the growing burden of dementia requires 
an understanding of the predictors of dementia in order to develop preventive strategies. 
Therefore, identifying potential associations between certain demographic and lifestyle 
characteristics and dementia may illuminate strategies for reducing the risk of dementia. 
This research analysis aims to highlight associations between demographic and lifestyle 
factors in midlife and dementia in later adulthood. 
Methods  
This is a secondary analysis of data that was collected as part of a longitudinal, 
prospective cohort study. Data from the Framingham Offspring cohort was analyzed 
using the Cox proportional hazards regression model to examine the associations between 
the demographic and lifestyle characteristics and the risk of developing dementia. The 
multivariate analysis controlled for medical history factors that may also impact dementia 
risk.  
Results  
There were 2462 dementia-free participants (aged ≥ 40 and ≤ 65 years) at baseline 
at the time of the 2nd exam cycle, during which all demographic, lifestyle, and medical 
  v 
history factors were collected. During the follow-up period, 286 dementia events were 
observed (11% of participants). In univariate models, advanced age was significantly 
associated with an increased risk of dementia, while education level, alcohol use (vs. no 
use), and wine consumption demonstrated statistically significant protective effects 
against the development of dementia. After controlling for medical history in the 
multivariate model, older age remained a significant risk factor for dementia.  
Conclusion  
This study supports established research regarding the relationship between 
advancing age and increased risk of dementia, and this significant association remained 
constant when controlling for factors such as gender and medical history. Further, the 
associations observed between alcohol consumption, and specifically wine, and dementia 
risk support continued research on alcohol use and its relationship with dementia; while 
these protective effects did not remain statistically significant in the multivariate model, 
other studies have observed significant associations between alcohol and dementia risk in 
adjusted analyses. Additional research would be helpful to further examine if there are 
any potential protective effects of alcohol, and determine whether consumption is a 
worthwhile preventative strategy. Overall, identifying potential risk factors for dementia 
is an important focus of study, due to the aging worldwide population, and the 
corresponding increasing significance of this disease. This analysis adds to the literature 
regarding the associations between certain demographic and lifestyle characteristics and 
the risk of dementia. 
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INTRODUCTION 
 
 Dementia is a general term used to describe a chronic and/or progressive decline 
in cognitive ability. This decline is represented by a range of symptoms; there is no one 
established cause or manifestation.1 The diagnostic criteria for all-cause dementia focus 
on cognitive or behavioral symptoms that interfere with one’s ability to function during 
usual activities; and further, these symptoms must represent a decline as compared to 
previous levels of functioning, and cannot result from transient delirium or another 
psychiatric disorder.2 In order to make a diagnosis of dementia, the impairment must 
manifest in at least two domains related to the following: acquiring and remembering 
new information, impaired reasoning, impaired visuospatial abilities, impaired language 
abilities, and changes in personality and/or behavior.2  
The most commonly diagnosed types of dementia are Alzheimer’s disease (AD) 
and vascular dementia; other types include Lewy Body dementia and frontotemporal 
dementia.31   
AD constitutes 60-80% of diagnosed cases of dementia, and is characterized by 
progressive memory loss and other declines in cognitive abilities serious enough to 
interfere with daily living.31 AD is presumed to be caused by proteins (beta amyloid and 
tau) accumulating in the brain and forming structures called 'plaques' and 'tangles,’ 
respectively.32 The plaques build up between the nerve cells of the brain due to an 
accumulation of beta-amyloid, while the neurofibrillary tangles form within the neurons, 
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due to a breakdown in the tau protein.36 These structures disrupt the connections between 
nerve cells, leading to the eventual death of these cells and the loss of brain tissue.32  
Vascular dementia is tied to conditions (such as strokes) that block or reduce 
blood flow to the brain. This in turn deprives brain cells of oxygen and nutrients, 
resulting in cognitive decline.33 Vascular dementia can manifest suddenly following an 
acute event, or can develop gradually due to worsening conditions in the brain over time.  
Lewy Body dementia, estimated to be the third most common type of dementia,34 
occurs when protein deposits develop in nerve cells in the brain. These deposits 
progressively damage regions responsible for thinking, memory and motor control.34 
People with Lewy body dementia most commonly experience visual hallucinations, 
changes in alertness and attention, and symptoms similar to Parkinson’s disease, such as 
tremors, rigidity, and slow movement.35 
Frontotemporal dementia encompasses a group of rare disorders that affect the 
frontal and temporal lobes of the brain.37 In this type of dementia, sections of these lobes 
of the brain shrink, resulting in extreme changes to behavior, problems with movement, 
and/or the loss of language abilities (such as aphasias). Frontotemporal dementia often 
begins at a younger age than AD, and is the most common form of dementia in 
individuals under the age of 60.38 
Dementia is a disease of worldwide significance; the World Health Organization 
estimated that 47.5 million people worldwide were living with dementia in 2015.3 This 
number is expected to double every twenty years, resulting in an estimated prevalence of 
131.5 million by 2050.4 Along with the difficulties experienced by those living with the 
 3 
disease, dementia places extremely high stressors on caregivers. Individuals caring for 
individuals with dementia are at an increased risk for stress, depression, and other health 
complications, and also show high rates of social isolation and financial hardship.5 
Research has shown that caring for a person with dementia is more stressful than caring 
for a person with a physical disability.6 The economic impact of dementia is also 
substantial; in the United States alone, the health care costs are estimated at 818 billion 
USD per year at present, and are expected to increase at a higher rate than the overall 
prevalence; experts forecast that dementia costs will reach a trillion dollars in the United 
States by 2018.4 As a result of these wide-ranging impacts, the medical field has devoted 
much time and resources to studying the causes and prevention of this disease.  
Research on the development of dementia has focused heavily on underlying 
physical risk factors; for example, studies have demonstrated an association between the 
incidence of ischemic and/or hemorrhagic stroke and an increased risk of dementia,7,8  as 
well as an association between low cardiac index and an increased relative risk of 
incident dementia and AD specifically.9 Other researchers have identified susceptibility 
genes; these are genetic mutations that, when inherited, result in an increased lifetime 
dementia risk.10, 11  
Medical history is not the only relevant factor, however; other studies have 
examined the association between certain lifestyle characteristics and the development of 
dementia and Alzheimer’s disease. In a longitudinal study of Japanese-American men, 
individuals who did not smoke and were physically active had a decreased risk of 
developing vascular dementia; and further, higher BMI was significantly associated with 
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a greater risk of all types of dementia. These findings are not consistent across all studies, 
however; there are differing hypotheses regarding the relationship between BMI and the 
development of dementia. Some scientists have theorized that certain hormones present 
in body fat, such as leptin and estrogen, have neuroprotective effects, and therefore a 
higher BMI in mid- and/or late-life may be associated with a lower risk of dementia.13,14 
Other researchers have observed an association between high BMI and an increased risk 
of dementia in longitudinal cohorts, and have hypothesized that these results are due in 
part to the chronic health issues that are often associated with obesity, such as 
cardiovascular disease, metabolic syndrome, and diabetes.15,16 Research into the 
association between these health issues and the risk of dementia has suggested that high 
inflammation levels contribute to cognitive impairment, as high inflammation levels 
increase the risk of damage to the vascular system.43 The damage to the blood vessels 
leads to conditions that affect the blood flow to the brain, resulting in microvascular 
effects and subclinical vascular disease.44 Yet, even the observed associations between 
these health issues and the risk of dementia are not consistent. A longitudinal study 
conducted in Italy found that metabolic syndrome (defined in the study as a clustering of 
cardiovascular risk factors including abdominal obesity, hypertension, dyslipidemia, and 
hyperglycemia) was not associated with a risk of dementia; and in older adults, metabolic 
syndrome was actually associated with a lower risk of AD.45   In an attempt to reconcile 
some of these differing results, researchers in 2011 conducted a meta-analysis of 15 
different prospective studies that examined the association of BMI and risk of dementia.17 
This analysis found that underweight BMI, overweight BMI and obese BMI were all 
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associated with increased risk of dementia, as compared to normal BMI; and further, that 
the risks were highest for underweight and obese BMI. These investigators did note that 
their results were limited by the study data; namely, the lack of consistent adjustments for 
health and demographic factors and other lifestyle choices such as diet, smoking, alcohol 
and physical activity. As these factors could influence the relationship between obesity 
and risk of dementia, it would be helpful to examine multiple factors in one cohort. 
Participation in leisure activities has also been associated with a reduced risk of 
dementia; in one study, mental, physical, and social components of lifestyle activities all 
contributed to this reduced risk, especially when participants posted high scores in all or 
two of these domains.18 Other scientists have examined possible links between 
personality traits and risk of dementia, such as a reduced risk of dementia in individuals 
with a combination of low neuroticism and high extraversion.19 Researchers have also 
studied the relationship between sleep and the risk of dementia, and have again arrived at 
different results. A recent analysis using data from the Framingham Heart Study (FHS) 
found that individuals who reported sleeping more than nine hours per night had double 
the risk of developing dementia after 10 years as compared to individuals who slept for 9 
hours or less.20 The study imaging results also showed that the individuals who slept 
longer had comparatively smaller brain volumes.20 In analyzing this association, these 
investigators posited that the differences in sleep times may indicate that excessive sleep 
is a symptom of dementia-related brain changes, rather than a  cause.20 Another research 
team examined the association between changes in sleep patterns over time and the risk 
of dementia. In a longitudinal study of Swedish adults aged 75 years and older, 28% of 
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participants were diagnosed with all-cause dementia between the 6th and 9th year post-
baseline. The researchers found that reduced sleep in this cohort (as compared to the 
amount of sleep reported at baseline) was associated with a 75% increased all-cause 
dementia risk, and that the risk for Alzheimer’s disease was doubled.21 These results 
remained after adjusting for all lifestyle and vascular factors, although not after adjusting 
for symptoms of depression. Again, however, the reduction in sleep from baseline may 
constitute a symptom, rather than a cause, of increasing cognitive impairment.  Despite 
the different findings, both study teams concluded that identifying sleep problems early 
on may help to detect early signs of dementia. 
Currently, despite substantial efforts, there is no effective treatment for the cure or 
prevention of certain subtypes of dementia, such as Alzheimer’s disease and Lewy Body 
dementia.22 There is a class of drugs called cholinesterase inhibitors that are used to 
provide short-term relief from the symptoms of Alzheimer’s disease, as well as slow the 
progression (by increasing the chemical acetylcholine that aids in memory and learning), 
but these medications are unable to ultimately cure the disease.61 In recent years, 
attention has shifted to trying to identify effective early intervention strategies, 
implemented at a stage when there is the time and potential to modify or slow disease 
progression.22-24 Identifying lifestyle characteristics that are associated with dementia is 
appealing, as this creates the potential for modifying behaviors in order to reduce the 
probability of developing dementia. A similar approach has been followed successfully in 
the cardiovascular field in the Framingham Heart Study (FHS) in 1970s.25-27 Researchers 
in other fields have also examined the effects of lifestyle changes on disease prevention; 
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studies have been conducted on the impact of behavioral modifications (such as weight 
loss, diet, and psychosocial stressors) in conditions as varied as gout, breast cancer, and 
polycystic ovary syndrome, for example.38, 39, 40The use of FHS lifestyle data to study the 
impact of preventative strategies for dementia have been more limited, however.   
Purpose 
While prior research has provided an important foundation for the investigation 
into how lifestyle factors are associated with the development of dementia and/or AD, 
further evidence is needed to better characterize and understand this relationship. An 
analysis of data from the Framingham Heart Study (FHS) Offspring Cohort will add 
valuable information to this area of cognitive and neurological research, as the research 
participants have provided data on an especially wide range of demographic and lifestyle 
characteristics. The FHS Offspring Cohort has been participating in this research study 
since 1971, and the comprehensive assessment of lifestyle factors during these exams, 
which have resulted in numerous discoveries regarding the implications for 
cardiovascular risk, provide a wealth of data for analyzing the associations between these 
factors and the development of dementia. Further, the 99% retention rate of participants 
regularly returning for scheduled examinations, 41 beyond demonstrating the dedication of 
the participants, provides a uniquely complete and valuable dataset for this analysis. In 
this study, we investigate how midlife demographic and lifestyle characteristics are 
associated with dementia risk. This analysis may lead to a clearer understanding of the 
effect of various lifestyle characteristics earlier in life on the development of dementia 
later in life, and inform effective preventative strategies in the future.  
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Primary Study Question 
How are demographic and lifestyle characteristics (age, gender, BMI, education, 
sleep, activity level, coffee, tea, alcohol use, tobacco use, and obesity) associated with the 
development of dementia? 
 9 
METHODS  
 
Study Design 
This is a secondary analysis of data that was collected as part of a longitudinal, 
prospective cohort study.  
Participants 
Initiated in 1948, the Framingham Heart Study is an ongoing, multi-generational 
longitudinal cohort study. The Original Cohort consisted of 5209 residents of 
Framingham, Massachusetts.28 Beginning in 1971, a total of 5214 children of the Original 
Cohort and their spouses were enrolled into the Offspring Cohort. The participants in the 
Offspring Cohort have completed up to 9 examinations, which have taken place on 
average about every 4 years.29 
At the second examination cycle (which took place from 1979 to 1983), the 
Offspring Cohort were screened for potential cognitive impairment, as described below 
under Dementia Surveillance. The demographic and lifestyle data used in this study were 
also collected at this second examination visit. In order to capture these data at midlife, 
the inclusion criteria for this analysis were dementia-free individuals in the FHS 
Offspring Cohort between 40 and 65 years of age at the time of the second examination.   
Institutional Review Board (IRB) approval was obtained from the BU Medical 
Campus/Boston Medical Center IRB for the secondary analysis of this data. All 
participants provided written informed consent under the auspices of the main study to 
allow for future use of their data for this type of secondary analysis. 
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Demographic and Lifestyle Variables 
The demographic characteristics and lifestyle factors were collected during the 
second examination using detailed self-report questionnaires, and a physical exam was 
conducted.  
The variables were defined as follows: Age at the time of the exam ranged from 
40 years to 65 years of age. Gender was defined as male or female. Body Mass Index 
(BMI) was calculated using height (cm) and weight (kg). Education level was calculated 
using years of education, and analyzed as a continuous variable. Smoking status was 
classified as current smoker (yes/no). Sleep was calculated based upon self-reported 
hours per day, and was analyzed both continuously and categorically, as hours of sleep 
per day, as well as defined by < 7 hours a day or ≥7 hours a day, according to the 
recommended daily sleep duration for adults 40 to 65 years of age46. Activity level was 
divided into four categories at the time of the FHS exam: sedentary, slight, moderate, and 
heavy. The participants self-reported the number of hours per day for each activity level. 
Obesity was calculated as No, Maybe, and Yes (as determined by the opinion of the FHS 
examiner). The answer of Maybe was included when a definitive determination could not 
be made based upon the available information. Maybe and Yes for obesity were analyzed 
as separate categories. Coffee and tea consumption were calculated as cups per day. 
Alcohol use was divided into three categories: beer, wine, and cocktails. For each 
category, participants provided the number of servings per week. Alcohol use was also 
categorized as drinkers or non-drinkers in the analysis; non-drinkers reported zero 
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alcohol consumption, while drinkers reported ≥1 serving per week of any of the three 
categories of alcohol.  
Medical History Variables:  
While there is no established agreement in the published literature on the 
association between cardiovascular risk factors and all-cause dementia, or cancer and 
dementia, for example, there are known relationships between these factors and certain 
subtypes, such as the relationship between vascular dementia and stroke. Due to the 
heterogeneity of the subtypes within all-cause dementia, and the potential for interplay 
between dementia diseases processes and other medical history, the following medical 
history risk factors of participants at the time of the 2nd cycle examination were included 
in the analysis as control variables. History of stroke and cancer, as well as current 
diagnosis of diabetes were calculated as No, Maybe, and Yes, based upon self-report and 
review of medical records at the time of the exam. If the examiner could not make a 
definitive determination, Maybe was used, based upon the evidence available at the time, 
as the determination was made on examiner opinion. Maybe and Yes for diabetes were 
analyzed separately. The categories Yes and Maybe for stroke and cancer were merged to 
allow for sufficient statistical power in the analysis, due to the low number of events in 
this population. Hypertension was measured as Normal, Definite, or Borderline. 
Dyslipidemia was measured as total cholesterol mg/dl and analyzed continuously. 
Outcome Measure 
The outcome measure was the diagnosis of dementia, as defined below. In brief, 
participants were screened for dementia continuously during the study, as well as after 
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death, if they died in 1989 or later.  For participants who were never diagnosed with 
dementia, date of death (if participant was deceased) or date of last exam were used for 
censoring in the analysis.  
Dementia Surveillance:  
At the second Offspring examination, all participants were initially screened for 
possible cognitive impairment using a subjective memory question.29 The initial cognitive 
screen used for serial tracking was the Mini-Mental State Examination (MMSE). In the 
Offspring Cohort, this screening has been administered at each examination since 1991. 
Any of the following participant scores results in an MMSE flag (the highest possible 
score is 30 points):  
● an absolute score of <23 for all persons; 
● a score <24 for persons with a high school education; 
● a score <26 for college-educated persons;  
● a decline of 3 points since the participant’s previous exam, or; 
● a decline of 5 points from their personal best score.  
These cut-off points are based on normative data and previous work conducted by the 
New Haven Epidemiologic Catchment Area Program.30 
Participants may also be flagged if they, or a family member or physician, 
expresses concern about their thinking either spontaneously or during an FHS study visit. 
After being flagged, when possible, participants are administered a full 
neuropsychological test battery. At the end of this battery, an FHS neuropsychologist 
(NP) administering the neuropsychological evaluation assigns an examiner impression 
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dementia NP severity ranging from 0 = not demented, to 0.25 = very slight concern that 
cognitive performance is below expected level but person does not have mild cognitive 
impairment or dementia, 0.5 = mild cognitive impairment, 1 = mildly demented, 1.5 = at 
least mildly demented, possibly more, 2 = moderately demented, 2.5 = at least 
moderately demented, possibly more, and 3 = severely demented, or 5 = non progressive 
impairment.  Participants with values between 0.5 and 3 are considered to have been 
flagged by NP, and those with values of 0, 0.25 are considered to not need further follow-
up.  
Participants flagged by this testing are then referred to an FHS neurologist who 
performs a neurological exam that includes a Clinical Dementia Rating (CDR) 
assessment. The cognitive test performance of participants assigned a dementia NP 
severity of 0.25 are discussed with a second senior neuropsychologist to decide if the 
person needs additional assessment by a neurologist. The neurologist’s impression of 
dementia severity is recorded as 0 = none, 1 = mild, 2 = moderate, and 3 = severe, 
corresponding to overall CDR scores of 1, 2 and 3. Values ≥ 1 are considered to 
constitute a Neurology (NE) flag which results in the person’s records being taken to 
dementia review (DR). 
Participants are brought to DR and reviewed by a panel consisting of at least one 
neurologist and one neuropsychologist, and this review may occur at multiple points 
during their individual cognitive tracking: when they are first suspected to have dementia, 
when the severity of their dementia changes, after death, and, if they have elected to be a 
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brain donor, for a final time after a clinical-pathological conference at which the ante-
mortem clinical and post-mortem pathological diagnoses are reviewed in tandem.   
Participants who are alive are evaluated at DR if they have been: 1) flagged by 
NE and have either never had a full DR, or their NE severity is greater than the severity 
recorded at a previous DR; or 2) flagged by NP and have not yet had a FHS neurology 
assessment or DR, and either live outside New England or live in New England but had 
the NP evaluation at least 1 year earlier and had NP severity >1. If participants decline 
the FHS neuropsychologist or neurologist assessments, they may still be flagged for 
review at DR based only on their medical record and, if available, a family interview. 
A separate review panel of FHS physicians performs a full post-mortem medical 
review of all deceased Framingham participants to establish date and cause of death, and 
to review medical records for cardiovascular events. Since 1989, this review has also 
looked for any mention of cognitive impairment in the records; this is considered to be a 
flag at death review. Participants who have died are evaluated for post mortem DR if 
they: 1) had an ante-mortem DR; 2) died after 1989 and were flagged prior to death by 
MMSE, NP, NE, or were flagged at post mortem medical review; 3) died before 1989 
and were flagged prior to death by MMSE, NP or NE; or 4) died before 1989 but after 
exam 14 (when the first cognitive battery was administered), with no flag.  
For cases that were detected before 2001, a repeat review was completed after 2001 so 
that up-to-date diagnostic criteria could be applied.29 In this analysis, participants were 
included if they did not have a diagnosis of dementia, based upon the above criteria, at 
the time of their 2nd examination visit. 
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Statistical Analysis 
Descriptive statistics were used to define the characteristics of the study sample. 
The Cox proportional hazards regression model was used to examine the associations 
between the explanatory variables (the above-defined demographic and lifestyle 
characteristics) and the risk of developing dementia. The Cox proportional hazards model 
allows for the calculation of dementia probability based upon the differing lengths of 
follow-up for each individual participant in this study (based upon diagnosis of dementia, 
date of death, or date of last exam). Censoring is used in statistical analysis when the time 
to the outcome event (in this case, diagnosis of dementia) is not available for all study 
participants.62 In this study, the majority of participants were by censored by using the 
date of death (if they have died) or date of last visit.  This is necessary because data on 
the time to dementia diagnosis for these participants was not available, because they 
either did not develop dementia prior to death or they have yet not developed dementia.  
The time to event or censorship was calculated in days in this analysis. The univariate 
analysis was unadjusted, and each explanatory variable was examined individually in the 
univariate model.  Hazard ratios (HRs) and 95% confidence intervals (95% CIs for HR) 
were calculated for the association between the demographic and lifestyle characteristics 
and the development of dementia, and p-values were calculated to determine statistical 
significance. While statistical significance in the univariate model was pre-defined by a 
p-value < 0.05, the significance required for inclusion in the multivariate model was less 
stringent.  If an explanatory variable met a pre-defined level of statistical significance (p-
value ≤ 0.20) in the univariate analysis, it was included in the second multivariate model.  
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The first multivariate analysis adjusted for age and gender alone; while gender was not 
significantly associated with dementia in the univariate model, age and gender are 
common covariates and prior research has suggested that women are at a higher risk of 
dementia (although this may be due to their longer lifespan). The second multivariate 
analysis adjusted for age, gender and the medical history risk factor control variables 
(stroke, diabetes, hypertension, cancer, and dyslipidemia). The analysis was conducted 
using R software i386 3.4.2 and RStudio Version 1.1.383. 
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RESULTS 
 
 
 There were 2462 dementia-free participants (aged ≥ 40 and ≤ 65 years) at baseline 
at the time of the 2nd exam cycle. The mean age of the participants at the time of the 
baseline exam was 49.9 years, and the gender distribution was nearly equal with females 
constituting 50.4% of the population. During the follow-up period, 286 dementia events 
were recorded in this study population (11% of participants).  
See Table 1 for the descriptive statistical analysis of this cohort. 
Table 1 Descriptive Statistics 
 
Total
Number Proportion (%) Mean Median
Age at baseline, years 2462 49.94 50
Gender
Female 1241 50.4
Education, years 13.59 13
BMI, Kg/m^2 25.48 26.04
Sleep, hours 7.34 7
Recommended Sleep
≥ 7 hours/night 1991 81
≤ 7 hours/night 468 19
Coffee, servings/week 2.84 2
Tea, servings/week 0.66 0
Alcohol User 
Yes 1851 75.2
Beer, servings/week 3.09 0
Wine, servings/week 1.89 0
Cocktails, servings/week 3.12 1
Obesity 
Yes 594 24.1
Maybe 94 3.8
Total
 18 
 
Univariate Models:  
As expected, older age was strongly associated with a higher risk of dementia, 
representing the most statistically significant relationship in this model (HR = 1.2, p = < 
.001). Education level was also significantly associated with dementia risk; each year of 
additional schooling resulted in a decreased risk of dementia (HR=0.9, p = < 0.001). 
Alcohol use was significantly associated with decreased risks of dementia compared to 
non-use (HR = 0.7, p = 0.013), and consumption of wine in particular demonstrated a 
protective effect from dementia in this model (HR = 0.95, p = 0.034). While not 
statistically significant, other lifestyle factors met the pre-defined threshold for inclusion 
in the second multivariate model, based upon a p-value ≤ 0.20. Higher BMI and obesity 
(Yes) demonstrated some association with an increased risk of dementia (HR =0.99, p 
Number Proportion (%) Mean Median
Activity Level
Sedentary, hours/day 5.91 5
Slight, hours/day 7.62 8
Moderate, hours/day 2.53 2
Heavy, hours/day 0.61 0
History of Stroke 
Yes 11 0.4
History of Cancer
Yes 62 2.5
Hypertension 
Yes 162 6.6
Borderline 607 24.6
Diabetes
Yes 49 1.9
Maybe 15 0.6
Dyslipidemia, total mg/dl 212.8 210
 19 
0.15; HR = 1.3, p = 0.066), while receiving the recommended duration of sleep per night 
(≥7 hours) demonstrated some minor protective effects from the risks of dementia (HR = 
0.79, p = 0.16). Gender and other lifestyle factors (total hours of sleep per day, coffee and 
tea consumption, tobacco use, beer and cocktail consumption, obesity (Maybe) and 
(Maybe + No combined), and hours of activity per day) were not significantly related to 
dementia risk.  
See Table 2 for the full results of the univariate analysis. 
Table 2 Univariate Models 
Variable  HR (95% CI for 
HR) 
p-value 
 
Age Years 1.2 (1.2 - 1.2) < 0.001^ 
Gender Female 1.1 (0.85 - 1.5) 0.42 
Education Years 0.9 (0.86 - 0.95) < 0.001^* 
BMI Kg/m
2 0.99 (0.99 - 1.1) 0.15* 
Sleep  Hours/Night 0.94 (0.83 - 1.1) 0.39 
Recommended 
Sleep  
≥ 7 
Hours/Night 
0.79 (.57 - 1.1) 0.16* 
Coffee Cups/Day 0.99 (0.94 - 1) 0.71 
Tea Cups/Day 0.93 (0.82 - 1) 0.22 
Alcohol User  Yes 0.7 (0.52 - 0.93) 0.013^* 
Beer Servings/Week 1 (0.98 - 1) 0.79 
Wine Servings/Week 0.95 (0.91 - 1) 0.034^* 
Cocktails Servings/Week 0.99 (0.96 - 1) 0.36 
Tobacco use Yes 0.86 (0.64 – 1.2) 0.31 
Obesity  Yes 1.3 (0.98 - 1.8) 0.066* 
Obesity  Maybe 1 (0.53 -2) 0.9 
Activity Level  
   
Sedentary Hours/Day 1 (0.95 -1) 0.85 
Slight Hours/Day 1 (0.96 -1) 0.84 
Moderate Hours/Day 1 (0.96 - 1.1) 0.44 
Heavy Hours/Day 0.96 (0.85 - 1.1) 0.49 
^statistical significance 
*included in multivariate model 
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Multivariate Model 1: 
In the first multivariate analysis, age and gender were included in the model. 
Advanced age remained a statistically significant risk for dementia (HR = 1.19, p = ≤ 
0.001), while gender demonstrated no association with the risk of developing dementia.  
Table 3 Multivariate Model 1 
Variable  HR (95% CI for 
HR) 
p-value 
Age Years 1.19 (1.16 - 1.22)  < 0.001 
Gender Female 1 (0.76 - 1.31) 0.996 
 
Multivariate Model 2: 
In the second multivariate analysis, the lifestyle factors which showed a 
statistically significant association with dementia risk in the univariate analysis were 
included in the model (age, education level, alcohol use, and wine consumption) along 
with those factors which trended significance, meeting the pre-defined threshold for 
inclusion (BMI, obesity (Yes), and recommended sleep duration (Y/N). 
The medical history variables were also included in this model, in order to 
account for their potential effects on the development of dementia. These included 
hypertension (Yes and Borderline), diabetes (Yes and Maybe), history of stroke, history 
of cancer, and dyslipidemia. 
After controlling for the relevant medical history, advanced age (per year of age) 
remained the only factor demonstrating a statistically significant association with 
dementia risk (HR = 1.18, p = < 0.001). In regards to medical history, participants with a 
history of cancer were more than twice as likely to develop dementia (HR = 2.11, p = 
0.007). A documented diagnosis of Maybe for diabetes was also associated with a higher 
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risk for dementia (HR = 3.68, p = 0.005). Interestingly, a Yes diagnosis of diabetes did 
not demonstrate a significant association. Also of note, history of stroke showed no 
statistically significant relationship with the development of dementia. 
See Table 4 for the full results of the second multivariate model analysis. 
Table 4 Multivariate Model 2 
Variable  HR (95% CI for 
HR) 
p-value 
Age Years 1.18 (1.15 - 1.21)  < 0.001* 
Gender Female 0.9 (0.67 - 1.20) 0.468 
Education Years 0.96 (0.91 - 1.02) 0.173 
BMI Kg/m
2 0.99 (0.96 - 1.05) 0.979 
Recommended Sleep  ≥ 7 Hrs/Night 0.93 (0.66 - 1.298) 0.657 
Alcohol Use  Yes 0.89 (0.64 - 1.23) 0.471 
Wine Servings/Week 0.97 (0.92 - 1.02) 0.177 
Obesity  Yes 1.02 (0.68 - 1.53) 0.931  
 
   
Medical History  
   
Stroke Yes 1.36 (0.54 - 3.38) 0.512 
Cancer Yes 2.11 (1.22 - 3.64) 0.007* 
Hypertension (Yes) Yes 1.03 (0.59 - 1.78) 0.927 
Hypertension (Borderline) Borderline 1.03 (0.75 - 1.41) 0.868 
Diabetes (Yes) Yes 0.43 (0.11 - 1.74) 0.236 
Diabetes (Maybe) Maybe 3.68 (1.48 - 9.12) 0.005* 
Dyslipidemia Total 
cholesterol 
mg/dl 
1 (0.997- 1.005) 0.572 
*statistically significant 
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DISCUSSION 
 
 The likelihood of developing dementia in each individual participant was 
analyzed based on the presence and/or level of the demographic and lifestyle 
characteristics, as well as the medical history of the participant.  
In all of the models, age was strongly associated with an increased risk of 
dementia, as would be expected from prior research and from the knowledge of the 
disease processes behind certain types of dementia.31-37Conversely, gender did not 
account for any differences in dementia risk, in any of the statistical models. This finding 
is similar to some previous research,48 but there is no widespread agreement in the 
literature; other studies have suggested that women do have an elevated risk of 
developing dementia, especially AD, perhaps due mostly to the fact that they live longer 
than men.46-47 The findings from this study support this theory that a higher prevalence in 
women is likely due to their longer average lifespan, which provides more opportunity to 
develop dementia. While the risk of dementia was not significantly higher in women in 
the univariate model, there was a very small association; this association completely 
disappeared, however, when controlled for by age in the multivariate model.  
The statistically significant protective effects of alcohol use seen in the univariate 
analyses are consistent with prior research findings examining light to moderate 
consumption.50-51, 53-54, 60 Wine consumption was specifically linked with significantly 
decreased risk of dementia in the univariate analysis, and demonstrated a mild protective 
association with dementia in the multivariate analysis.  These findings agree with 
previous studies51, 54, including a similar Swedish population-based study examining 
 23 
midlife alcohol consumption.52 A meta-analysis performed on 143 prior studies on the 
association between alcohol use and dementia demonstrated that moderate drinkers were 
23 percent less likely to develop cognitive impairment or AD and other forms of 
dementia, and that wine demonstrated the most beneficial effects.54 A number of potential 
factors have been hypothesized to be behind these findings; for example, that individuals 
who are more social are also more likely to be alcohol consumers (or vice versa), and that 
the resulting social support networks and interpersonal interactions later in life help 
protect against the onset of dementia. Other researchers have posited that it is due to the 
known cardiovascular effects of certain types of alcohol, and/or that the cellular stresses 
induced by alcohol increases the cells’ ability to cope with more major stressors in 
advanced age that could otherwise cause dementia.54  The results of this analysis cannot 
definitively support any of these hypothesized reasons behind the protective association 
between alcohol use and dementia, however, as the significant links disappeared when 
adjusted for in the multivariate model. Instead, it is possible that confounding was 
responsible for the significant association between dementia risk and alcohol use seen in 
the univariate model. Alcohol use has been shown to be associated with years of 
education, for example; highly educated individuals are more likely to drink alcohol.65 It 
may be that the lower risk of dementia in alcohol users seen in the univariate model was 
wholly or partly due to the higher education level of these participants, as more years of 
education was also associated with lower risks of dementia. Similarly, previous research 
has also shown that American individuals with a higher socioeconomic status are more 
likely to drink alcohol.65 Higher socioeconomic status is also associated with lower risks 
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of dementia, and therefore this may be another factor that confounded the relationship 
between alcohol use and dementia risk. Older age was significantly associated with 
dementia in all models; it is possible that younger individuals were more likely to be 
alcohol users. If this was true, this would have led to the protective effects of alcohol use 
seen in the univariate model, and would explain why this association disappeared in the 
multivariate analysis. While the protective effects of alcohol shown in the univariate 
model are consistent with previous research, this observed relationship may have been 
caused solely by the interplay of other factors.  
Education level also demonstrated significant protective effects against dementia 
in the univariate model.   Other than the link between advanced age and increased risk of 
dementia, this protective effect of education level also represents the closest association 
with dementia risk in the multivariate analysis. The mechanism behind this association is 
not entirely clear. In prior studies, poor scores on the cognitive screening tests have been 
considered as a potential cause behind observed links between low education and 
cognitive decline,55 but in the Framingham Heart Study, participants were flagged for 
dementia review based upon on a decline in cognitive ability; the thorough dementia 
review panel helps ensure that dementia diagnoses are not based upon low cognitive 
ability at baseline. The neuropsychological instruments administered to the FHS 
participants are also very sensitive; and thus, while the highly educated may look better 
on the surface, the researchers were able to determine whether the participants had 
declined significantly as compared to their original baseline. Higher education level may 
be associated with decreased risk of dementia due to corresponding higher 
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socioeconomic status, which could result in healthier diet, more free time for exercise, 
and increased access to health care. These socioeconomic differences provide a more 
intuitive explanation for the protective effects of education level, as compared to any 
neuroprotective processes created purely as a result of more years of schooling. 
In the multivariate analysis, the lack of a significant association between an 
increased risk of dementia and a history of stroke and/or a definitive diagnosis of diabetes 
was surprising, as the vascular damage caused by these conditions contributes to the 
development of certain types of dementia.7-8,33 This may have resulted from the use of all-
cause dementia as the outcome of interest. While vascular dementia is known to be 
caused by vascular issues such as stroke and diabetes, other types of dementia, such as 
Lewy Body dementia and Parkinson’s disease dementia are not related to stroke, and 
therefore this result would not be unexpected. Further, a noted previously, diabetes was 
classified as No, Yes, and Maybe, based upon examiner opinion, and the classification of 
Maybe did demonstrate a strong significant association with an increased risk of 
dementia in the multivariate analysis. It is possible that diabetes pathology was beginning 
in these participants in midlife, and the resulting disease progression over time played a 
role in their increased risk of dementia development.  
A history of cancer diagnosis was also significantly related to an increased risk of 
dementia in the multivariate analysis. This may be due to changes in mental health after 
the illness and/or as a result of the negative consequences of cancer treatment on overall 
health; certain chemotherapy medications, for example, have neurotoxic effects.56 Other 
researchers have posited that the relationship between cancer and dementia is due to 
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similar exposures and risk factors, such as smoking, diabetes and obesity (although these 
factors were not associated with dementia risk in this study), or shared genetic pathways. 
It is important to note, however, that there is a discrepancy between the results of this 
study and a prior study using FHS data.57 In the previous study, cancer survivors had a 
lower risk of AD than those without cancer, and patients with AD had a lower risk of 
cancer. This previous analysis, therefore, suggested an inverse association between 
dementia risk and cancer incidence.57 The previous study examined all types of cancer, 
however, rather than a general diagnosis of cancer, as was analyzed in this study, and also 
included data from both the FHS Original and Offspring cohorts. 
The major strength of this study is the longitudinal nature of the follow-up for the 
outcome of interest, as the cohort underwent over 30 years of rigorous dementia 
surveillance. The 99% retention rate of participants regularly returning for scheduled 
examinations41 provides a uniquely complete and valuable dataset for this analysis.  It 
should be noted, however, that there are several limitations in this study.  
It is possible that the identified associations may not be fully generalizable to 
other populations, due to the demographic breakdown of the Framingham Heart Study. 
FHS is comprised largely of whites of European descent, and individuals with Italian, 
Irish and English ancestry make up the majority of the cohort.58 About 85% of the 
Original Cohort was born in the U.S. or Canada, and 35% reported ethnic origins in the 
British Isles; another 19% are of Italian ethnicity, 32% are of other Western European 
ancestry, 5% Canadian and 6% Eastern European. Less than 4% of the cohort are of non-
European origins or of unknown ethnicity.58 These demographics affect the 
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generalizability of the data because prior researchers have observed differences between 
ethnic groups in regards to rates of dementia. In the United States, the majority of 
research has found higher rates of dementia in Hispanics and non-Hispanic blacks, as 
compared to non-Hispanic whites,63 for example, and a lower incidence of dementia in 
Asian-Americans as compared to all other groups.64 There are a number of possible 
reasons for these differences in dementia rates across ethnic groups. In some cases, the 
rates could be artificially high; differences in culture and language may impact the results 
of cognitive testing, for example. Health-related factors may also play a role; differences 
in genetic makeup may result in increased risk, whether due to genes that have been 
identified as related to dementia risk (such as APOE), or genetic factors that influence 
other medical issues that are associated with dementia (such as diabetes or Parkinson’s 
Disease). And further, these medical issues do not need to be caused by genetics to differ 
among ethnic groups; medical risk factors such as stroke and diabetes could differ 
between ethnicities for socioeconomic or environmental factors, rather than genetics.  
The homogenous nature of the FHS study population therefore needs to be considered 
when generalizing these results to other races and ethnic backgrounds, as they are not 
represented in this research.  
Second, family history and/or genetics, which represent additional risk factors of 
dementia, were not measured in this study. The APOE genotype, for example, has been 
identified as significantly related to the development of dementia and AD.59 These factors 
were not included in the analysis due to the limitation of the data collected via the 
questionnaires and review of the medical records. These variables were not assessed 
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during the 2nd cycle Offspring examination; and therefore, we were unable to determine 
their association with the development of dementia or control for their presence, as we 
only used data collected during this visit. The inclusion of these additional factors in 
future research may serve to further illuminate the nature of the association between 
various demographic and lifestyle characteristics and dementia risk.  
Third, the analyses in this study focused on overall dementia incidence; this study 
did not examine the results by each individual dementia subtype. Due to different disease 
processes and underlying pathologies, it is possible that specific risk factors may be 
different for AD and vascular dementia, for example, or among the other previously-
described types of dementia. In this study, the aim was to identify demographic and 
lifestyle characteristics that are associated with the risk of dementia, in order to highlight 
modifiable behaviors that the average individual could change to reduce their probability 
of developing dementia. As such, we used all-cause dementia as the outcome of interest; 
from a purely practical standpoint, individuals would aim to modify behaviors and other 
lifestyle characteristic in the hope of preventing any type of dementia, and not just one 
specific subtype. Examining potential differences between the relationships of 
demographic and lifestyle characteristics and individual dementia subtypes will be an 
important next step, however, for future research in this domain. 
Fourth, the demographic and lifestyle characteristics that were included in this 
study were measured at one time-point in this analysis (Examination 2), rather than 
longitudinally. It is possible that some of these characteristics may have changed during 
the 30-year follow-up period. Also, lifestyle factors are usually measured as time-
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dependent covariates, but were analyzed as fixed in this analysis. The lifestyle variables 
were measured in this manner intentionally, however; evaluating these characteristics in 
midlife, years prior to the onset of dementia, facilitated the analysis of potentially 
contributing long-term factors, as compared to examining characteristics that may only be 
present in later years. And further, preclinical AD, for example, may be present years 
before any noticeable or evaluable symptoms manifest;59 midlife measurement of these 
demographic and lifestyle factors may therefore provide a more accurate baseline for the 
analysis and  of their associations with AD risk.  
In conclusion, this secondary analysis of data that was collected as part of a 
longitudinal, prospective cohort study supports prior research regarding the relationship 
between advancing age and increased risk of dementia. This significant association 
remained constant when controlling for factors such as gender and medical history. In 
regards to the demographic and lifestyle characteristics, the majority of the variables 
studied did not demonstrate any meaningful relationship with dementia risk. The results 
of the univariate analyses did, however, identify three factors that showed some 
protective effects; education level, alcohol use, and wine consumption. While these 
associations were significant in the univariate analysis, the results were not conclusive, as 
none of these relationships remained significant when controlled for in the multivariate 
analysis. While the associations demonstrated in the univariate analysis may therefore 
have been solely caused by confounding, it may be worthwhile to continue studying 
moderate consumption of alcohol, specifically wine, and its relationship with dementia, 
as other studies have returned significant protective effects in adjusted analyses; 
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continued research in this area would be helpful to further examine the potential 
protective effects of alcohol, and determine whether consumption could be used as an 
appropriate preventative strategy, or whether this observed association is only due to the 
interplay of confounding factors. Overall, identifying potential risk factors for dementia 
is an important focus of study, due to the aging worldwide population and the increasing 
significance of this disease. On an individual level, dementia causes debilitating adverse 
effects for both the sufferer and the caregiver(s), and identification of preventative 
strategies could help mitigate the projected rise in incidence. This analysis adds to the 
growing literature regarding the associations between certain demographic and lifestyle 
characteristics and the risk of dementia. 
Future research in this area should continue to focus on studying the association 
between lifestyle characteristics and dementia risk, as identifying modifiable behaviors 
would provide practical utility for patients and physicians. Future analyses could examine 
potential links between midlife factors and specific dementia subtypes; as Alzheimer’s 
disease represents such a sizable proportion of diagnosed dementia cases, it would be 
worthwhile to identify modifiable behaviors that are linked with the buildup of plaques 
and neurofibrillary tangles, for example. Other research could examine lifestyle factors 
over time. In this study, the lifestyle factors were fixed as they were only measured at one 
time point; future analyses could incorporate longitudinal measurements throughout 
midlife, in order to examine the effects of certain characteristics remaining constant or 
changing in different participants, and the subsequent impact on the probability of 
developing dementia. Researchers should also continue to look beyond the scope of the 
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relationship between demographics and lifestyle characteristics and dementia. It will be 
important for investigators to identify biological markers that indicate the presence of 
dementia, as currently the only validated way to confirm the diagnosis is via documented 
cognitive decline.66 Researchers have identified some promising biomarkers in 
Alzheimer’s disease and Lewy Body dementia, such as the presence of certain proteins in 
blood and cerebrospinal fluid, and changes within the brain that are detectable by 
neuroimaging, but more studies are needed to validate these methods.66,67 Validated 
biomarkers would help with the drug development process; the identification of physical 
biomarkers may help scientists understand the physical processes underlying these 
diseases, and the effects of investigational medications could be measured by changes to 
the biomarkers. And further, if clinicians were able to rely on validated biomarkers to 
make diagnoses, this would enable earlier detection of the disease, and thus treatment and 
lifestyle changes could be started at a less advanced stage. Finally, investigators should 
continue to study the genetic factors behind dementia. Identifying and isolating the genes 
that cause or contribute to the development of dementia would help scientists understand 
the cellular mechanisms behind dementia-related neurological changes and assist in both 
screening and drug development. The progression and improvement of different gene-
editing technologies offers exciting potential for the treatment of dementia, but genetic 
pathways linked to the different subtypes need to be identified in order to test this type of 
treatment in future clinical trials. These future directions for dementia research are crucial 
to determining methods to detect, diagnose, and treat this disease. 
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